Back

Risk and benefit trade-off of thromboprophylaxis in patients with Fontan circulation: insights from the National Database of Health Insurance Claims of Japan

26 August 2022 (16:15 - 17:00)
Organised by:
Congress Presentation Part of: Markers of severity and tools to handle the Fontan circulation Pharmacotherapy ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Mr Masayoshi Hosoi

Showa University, Tokyo (Japan)

7 More presentations in this session

Presentation thumbnail
Changes in birth prevalence of hypoplastic left heart syndrome over the past half-century in Sweden
Mr K. Giang (Gothenburg, SE)
Abstract Slides
Presentation thumbnail
The outcomes of Fontan operation in patients with hypoplastic left heart syndrome (HLHS) versus other forms of univentricular heart
Professor A. Bielecka-Dabrowa (Lodz, PL)
Abstract Slides
Presentation thumbnail
Cardiopulmonary exercise testing in Fontan patients: unmasking the secret of Super-Fontans
Miss M. Paiva (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Strategies for thromboprophylaxis in Fontan circulation: A network meta-analysis
Doctor T. Alsaied (Pittsburgh, US)
Abstract Slides
Presentation thumbnail
Lymphopenia and immunoglobulin deficiency in adult patients with a Fontan circulation
Doctor M. Possner (Bern, CH)
Abstract Slides

Access the full session

Session thumbnail
Markers of severity and tools to handle the Fontan circulation

The Event

Event poster

ESC Congress 2022

26 August 2022 16:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources